Concepedia

Mathilde R. W. de Jong

MR

5

Publications

106

Citations

5

H-Index

2018

Active since

Affiliations

University of Groningen(Current)

University Medical Center Groningen

Mathilde R. W. de Jong is an author at University of Groningen specializing in immunology, medicine, and tumor biology.

Top concepts

MedicineImmunologyTumor BiologyPathologyCell DeathCell BiologyImmunotherapyCancer ResearchTumor MicroenvironmentGenetics

Publications per year

2018–2022

5

Publications

5

WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage

Mathilde R. W. de Jong, Myra Langendonk, Bart Reitsma et al. · Cancers · 2019 · 27 citations · Full text

Dna Damage, Genetics, Apoptosis +16

Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach

Mathilde R. W. de Jong, Lydia Visser, Gerwin Huls et al. · PLoS ONE · 2018 · 23 citations · Full text

Immunology, Pathology, Relevant Drugable Targets +16

Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma

Mathilde R. W. de Jong, Myra Langendonk, Bart Reitsma et al. · International Journal of Molecular Sciences · 2019 · 21 citations · Full text

Immunology, Pathology, Cell Death +18

Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma

Myra Langendonk, Mathilde R. W. de Jong, Nienke Smit et al. · Blood Cancer Journal · 2022 · 20 citations · Full text

WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma

Mathilde R. W. de Jong, Myra Langendonk, Bart Reitsma et al. · Therapeutic Advances in Hematology · 2020 · 15 citations · Full text

Rows per page

1–5 of 5